{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:07:12Z","timestamp":1790809632961,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K15345"],"award-info":[{"award-number":["22K15345"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.xphs.2024.02.027","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T07:06:55Z","timestamp":1709363215000},"page":"1674-1681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mechanism of Induction of P-gp Activity During MET Induced by DEX in Lung Cancer Cell Line"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7354-578X","authenticated-orcid":false,"given":"Wangyang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3421-5398","authenticated-orcid":false,"given":"Xieyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sunakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyanage Manosika Buddhini","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2506-1742","authenticated-orcid":false,"given":"Larasati","family":"Martha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Mizoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5197-038X","authenticated-orcid":false,"given":"Takuo","family":"Ogihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2024.02.027_bib0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.xphs.2024.02.027_bib0002","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer progress and priorities: lung cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.xphs.2024.02.027_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11060-004-8093-6","article-title":"Brain metastases: epidemiology and pathophysiology","volume":"75","author":"Gavrilovic","year":"2005","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.xphs.2024.02.027_bib0004","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13402-017-0345-5","article-title":"Lung cancer-associated brain metastasis: molecular mechanisms and therapeutic options","volume":"40","author":"Yousefi","year":"2017","journal-title":"Cell Oncol"},{"key":"10.1016\/j.xphs.2024.02.027_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-8722-7-19","article-title":"Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions","volume":"7","author":"Guo","year":"2014","journal-title":"J Hematol Oncol"},{"issue":"10","key":"10.1016\/j.xphs.2024.02.027_bib0006","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","article-title":"EMT, MET, plasticity, and tumor metastasis","volume":"30","author":"Bakir","year":"2020","journal-title":"Trends Cell Biol"},{"issue":"5","key":"10.1016\/j.xphs.2024.02.027_bib0007","doi-asserted-by":"crossref","first-page":"393","DOI":"10.12998\/wjcc.v3.i5.393","article-title":"Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: an update","volume":"3","author":"Gurzu","year":"2015","journal-title":"World J Clin Cases"},{"issue":"6","key":"10.1016\/j.xphs.2024.02.027_bib0008","doi-asserted-by":"crossref","first-page":"831","DOI":"10.15252\/emmm.201404396","article-title":"ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat","volume":"7","author":"Meidhof","year":"2015","journal-title":"EMBO Mol Med"},{"issue":"7579","key":"10.1016\/j.xphs.2024.02.027_bib0009","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.xphs.2024.02.027_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/14712598.2021.1869209","article-title":"The role of nivolumab combined to immunotherapy and\/or chemotherapy in the first-line treatment of advanced non small cell lung cancer","volume":"21","author":"Rocco","year":"2021","journal-title":"Expert Opin Biol Ther"},{"issue":"21","key":"10.1016\/j.xphs.2024.02.027_bib0011","doi-asserted-by":"crossref","first-page":"12840","DOI":"10.1111\/jcmm.15875","article-title":"Inhibitory effect of Ubenimex combined with fluorouracil on multiple drug resistance and P-glycoprotein expression level in non-small lung cancer","volume":"24","author":"Wan","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.xphs.2024.02.027_bib0012","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1208\/s12248-015-9757-1","article-title":"Multidrug Resistance Proteins (MRPs) and cancer therapy","volume":"17","author":"Zhang","year":"2015","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.xphs.2024.02.027_bib0013","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/jphp.13225","article-title":"Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines","volume":"72","author":"Yano","year":"2020","journal-title":"J Pharm Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2024.02.027_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060806","article-title":"Slug mediates MRP2 expression in non-small cell lung cancer cells","volume":"12","author":"Zhang","year":"2022","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.xphs.2024.02.027_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113352","article-title":"Physiological roles of ERM proteins and transcriptional regulators in supporting membrane expression of efflux transporters as factors of drug resistance in cancer","volume":"12","author":"Ogihara","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.xphs.2024.02.027_bib0016","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/j.xphs.2022.09.025","article-title":"P-glycoprotein-mediated pharmacokinetic interactions increase pimozide hERG channel inhibition","volume":"111","author":"Morishita","year":"2022","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2024.02.027_bib0017","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1248\/bpb.b15-00392","article-title":"Recommended daily dose of sesame lignans has no influence on oral absorption of P-glycoprotein substrates in rats","volume":"38","author":"Tomono","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.xphs.2024.02.027_bib0018","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ebiom.2015.12.009","article-title":"P-glycoprotein mediates ceritinib resistance in anaplastic lymphoma kinase-rearranged non-small cell lung cancer","volume":"3","author":"Katayama","year":"2016","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.xphs.2024.02.027_bib0019","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.xphs.2020.03.008","article-title":"Moesin-mediated p-glycoprotein activation during snail-induced epithelial-mesenchymal transition in lung cancer cells","volume":"109","author":"Kamioka","year":"2020","journal-title":"J Pharm Sci"},{"issue":"34","key":"10.1016\/j.xphs.2024.02.027_bib0020","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.3748\/wjg.v21.i34.9887","article-title":"Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer","volume":"21","author":"Kim","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"22","key":"10.1016\/j.xphs.2024.02.027_bib0021","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1016\/j.febslet.2010.10.038","article-title":"Glucocorticoid induces mesenchymal-to-epithelial transition and inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and cell migration","volume":"584","author":"Zhang","year":"2010","journal-title":"FEBS Lett"},{"issue":"8","key":"10.1016\/j.xphs.2024.02.027_bib0022","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI28084","article-title":"Glucocorticoids suppress bone formation via the osteoclast","volume":"116","author":"Kim","year":"2006","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.xphs.2024.02.027_bib0023","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1113\/jphysiol.2007.143073","article-title":"Effect of dexamethasone on skeletal muscle Na+,K+ pump subunit specific expression and K+ homeostasis during exercise in humans","volume":"586","author":"Nordsborg","year":"2008","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.xphs.2024.02.027_bib0024","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jphs.2019.04.007","article-title":"Dexamethasone changes the pharmacokinetics of amitriptyline and reduces its accumulation in rat brain: the roles of P-gp and cyp3a2","volume":"140","author":"Wen","year":"2019","journal-title":"J Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.xphs.2024.02.027_bib0025","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1167\/iovs.11-9337","article-title":"Expression and activity of p-glycoprotein elevated by dexamethasone in cultured retinal pigment epithelium involve glucocorticoid receptor and pregnane X receptor","volume":"53","author":"Zhang","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.xphs.2024.02.027_bib0026","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13402-020-00576-8","article-title":"Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt\/beta-catenin signaling regulation","volume":"44","author":"Shome","year":"2021","journal-title":"Cell Oncol"},{"issue":"1","key":"10.1016\/j.xphs.2024.02.027_bib0027","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1038\/s41598-019-43021-z","article-title":"OVOL2 induces mesenchymal-to-epithelial transition in fibroblasts and enhances cell-state reprogramming towards epithelial lineages","volume":"9","author":"Watanabe","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xphs.2024.02.027_bib0028","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12272-013-0276-2","article-title":"Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system","volume":"37","author":"Kibria","year":"2014","journal-title":"Arch Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2024.02.027_bib0029","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2133\/dmpk.DMPK-14-RG-042","article-title":"Involvement of moesin in the development of morphine analgesic tolerance through P-glycoprotein at the blood-brain barrier","volume":"29","author":"Kobori","year":"2014","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.xphs.2024.02.027_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12929-016-0246-3","article-title":"A glimpse of the ERM proteins","volume":"23","author":"Ponuwei","year":"2016","journal-title":"J Biomed Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T05:02:54Z","timestamp":1739422974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0022354924000832"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.02.027","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of Induction of P-gp Activity During MET Induced by DEX in Lung Cancer Cell Line","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}